文献速递血栓与止血

PROZ基因功能缺失与英国生物银行中缺血性卒中风险增加相关

Loss of function in protein Z (PROZ) is associated with increased risk of ischemic stroke in the UK Biobank.
PubMed 文献 · J Thromb Haemost · 2024-10-09

基于英国生物银行416711名参与者的全外显子测序数据,识别出414名携带PROZ罕见功能缺失变异者,其非心源性栓塞性缺血性卒中风险显著增加(OR 2.34,95%CI 1.15-4.13,P=0.02),而静脉血栓栓塞、心肌梗死和外周动脉疾病风险未见增加。血浆蛋白质组学显示变异携带者中PRDX1和PRDX6水平显著升高。

要点

  • PROZ罕见功能缺失变异携带者非心源性栓塞性缺血性卒中风险增加(OR 2.34)。
  • 变异携带者静脉血栓栓塞、心肌梗死和外周动脉疾病风险未见显著增加。
  • 变异携带者血浆PRDX1和PRDX6水平显著升高(倍数变化1.83和1.78)。

核心结论

  • 终生暴露于较低PZ水平与NCEIS风险显著增加相关,与PZ作为抗凝因子的作用一致。

研究设计与样本

  • 利用英国生物银行416711名参与者的全外显子测序和临床数据,识别PROZ罕见(次要等位基因频率≤0.1%)推定功能改变变异携带者。
  • 采用Firth逻辑回归并控制已知卒中危险因素,评估变异携带状态与非心源性栓塞性缺血性卒中的关联。
  • 在48893名UKB参与者亚组中评估PROZ变异携带者与非携带者之间1472种血浆蛋白水平的差异。

主要发现

  • 经缺失数据处理后,共识别出414名携带PROZ合格变异的UKB参与者(99.0%为杂合子)。
  • 变异携带者NCEIS风险显著增加(OR 2.34;95%CI 1.15-4.13;P=0.02),但静脉血栓栓塞、心肌梗死或外周动脉疾病风险未见增加。
  • 血浆蛋白质组学分析显示,PROZ变异携带者中两种与脑缺血反应相关的蛋白水平显著升高:PRDX1倍数变化1.83(P=1.3×10^-5),PRDX6倍数变化1.78(P=9.6×10^-10)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The vitamin K-dependent coagulation factor protein Z (PZ), encoded by the PROZ gene, is canonically considered to have anticoagulant effects through negative regulation of factor Xa. Paradoxically, higher circulating PZ concentrations have repeatedly been associated with an elevated risk of acute ischemic stroke. OBJECTIVES: We performed a large-scale genetic association study to examine the relationship between germline genetic variants in PROZ and the risk of ischemic stroke. METHODS: Using whole-exome sequencing and clinical data for 416 711 participants in the UK Biobank (UKB), we identified individuals with rare (minor allele frequency ≤0.1%) putatively function-altering variants in PROZ. Using Firth's logistic regression and controlling for known stroke risk factors, we evaluated the association between variant carrier status and noncardioembolic ischemic stroke (NCEIS). Additionally, we evaluated differences in the plasma levels of 1472 proteins between PROZ variant carriers and noncarriers in a subset of 48 893 UKB participants. RESULTS: After accounting for missing data, qualifying variants in PROZ were identified in 414 UKB participants (99.0% heterozygous). Variant carriers had a significantly increased risk of NCEIS (odds ratio, 2.34; 95% CI, 1.15-4.13; P = .02) but not of venous thromboembolism, myocardial infarction, or peripheral artery disease. Plasma proteomics analysis revealed that PROZ variant carriers had significantly elevated levels of 2 proteins related to the response to cerebral ischemia, peroxiredoxins 1 and 6 (PRDX1: fold change, 1.83; P = 1.3 × 10-5; PRDX6: fold change, 1.78; P = 9.6 × 10-10). CONCLUSION: Lifelong exposure to decreased PZ levels confers a significantly increased risk of NCEIS, consistent with the role of PZ as an anticoagulant factor.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Haj AK, Ryu J, Jurgens SJ, et al. Loss of function in protein Z (PROZ) is associated with increased risk of ischemic stroke in the UK Biobank. J Thromb Haemost. 2024. PMID: 39383998. doi:10.1016/j.jtha.2024.09.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。